01.05.2013
- Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said...
30.04.2013
- Zoetis, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer, posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in...
25.04.2013
- Biogen reported higher-than-expected first quarter profit on Thursday and raised its full year forecasts, and the U.S. biotechnology said it sees its new drug Tecfidera becoming...
12.04.2013
- U.S. investment firm Royalty Pharma is considering sweetening its $6.6 billion offer for Irish drugmaker Elan by paying Elan shareholders more if the multiple sclerosis drug...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
19.03.2013
- Drug sales will shrink further in France this year as government austerity measures curb healthcare spending in Europe's second-biggest drugs market, a study said on Tuesday. The...
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
26.02.2013
- NBGI Private Equity today announces the acquisition of Stiplastics for an undisclosed sum. Stiplastics is a specialist manufacturer of injection-molded plastic dosing, packaging...
22.02.2013
- German Industriepark Höchst has reached another milestone. On January 31, 1863, exactly 150 years ago, "Theerfarbenfabrik Meister, Lucius & Co.", the predecessor of Farbwerke...
